Skip to main content

Advertisement

Log in

Comparative Analysis of Enbloc or Piecemeal Removal After Enbloc Resection of Gastrointestinal Stromal Tumors

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Objective

To investigate the safety and prognosis of enbloc or piecemeal removal after enbloc resection of a gastric GIST by comparing the clinical data of endoscopic en block resection and piecemeal removal (EP) and en block resection and complete removal (EC) of gastric GISTs.

Methods

A total of 111 (43 endoscopic piecemeal, and 68 complete removal) patients with gastric GIST’s ≥ 2 cm in diameter who underwent endoscopic therapy from January 2016 to June 2020 at the First Affiliated Hospital of Zhengzhou University were retrospectively analyzed. In all cases, it was ensured that the tumor was intact during the resection, however, it was divided into EP group and EC group based on whether the tumor was completely removed or was cut into pieces which were then removed. The patients' recurrence-free survival rate and recurrence-free survival (RFS) were recorded.

Results

There was no statistically significant difference in RFS rates between the two groups (P = 0.197). The EP group had relatively high patient age, tumor diameter, risk classification, and operation time. However, there was no statistically significant difference in the number of nuclear fission images, postoperative hospitalization time, postoperative fasting time, complication rate and complication grading between the two groups (P > 0.05).

Conclusion

Endoscopic piecemeal removal after en block resection of gastric GIST is safe and effective and achieves similar clinical outcomes as complete removal after en block resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Al-Share B, Alloghbi A, Al Hallak M et al. Gastrointestinal stromal tumor: a review of current and emerging therapies. Cancer Metastasis Reviews. 2021;40:625–641.

    Article  CAS  PubMed  Google Scholar 

  2. von Mehren M, Kane J, Bui M, et al. NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021. Journal of the National Comprehensive Cancer Network: JNCCN. 2020;18:1604–12.

  3. Zhu H, Zhao S, Jiao R, Zhou J, Zhang C, Miao L. Comparison of endoscopic versus laparoscopic resection for gastric gastrointestinal stromal tumors: A preliminary meta-analysis. Journal of Gastroenterology and Hepatology. 2020;35:1858–1868.

    Article  CAS  PubMed  Google Scholar 

  4. Liu Y, Liu X, Fang Y et al. Comparison of safety and short-term outcomes between endoscopic and laparoscopic resections of gastric gastrointestinal stromal tumors with a diameter of 2–5 cm. Journal of Gastroenterology and Hepatology. 2022;37:1333–1341.

    Article  PubMed  Google Scholar 

  5. Wang C, Gao Z, Shen K et al. Safety and efficiency of endoscopic resection versus laparoscopic resection in gastric gastrointestinal stromal tumours: A systematic review and meta-analysis. European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2020;46:667–674.

    Article  PubMed  Google Scholar 

  6. Du C, Chai N, Linghu E et al. Clinical outcomes of endoscopic resection for the treatment of gastric gastrointestinal stromal tumors originating from the muscularis propria: a 7-year experience from a large tertiary center in China. Surgical Endoscopy. 2022;36:1544–1553.

    Article  PubMed  Google Scholar 

  7. Wang D, Ding Q, Cao L et al. Clinical outcomes of endoscopic treatment for gastric gastrointestinal stromal tumors: a single-center study of 240 cases in China. Scandinavian Journal of Gastroenterology 2022;57:996–1004.

    Article  CAS  PubMed  Google Scholar 

  8. Kim G, Choi K, Gong C et al. Comparison of the treatment outcomes of endoscopic and surgical resection of GI stromal tumors in the stomach: a propensity score-matched case-control study. Gastrointestinal Endoscopy. 2020;91:527–536.

    Article  PubMed  Google Scholar 

  9. Nishida T, Goto O, Raut C, Yahagi N. Diagnostic and treatment strategy for small gastrointestinal stromal tumors. Cancer. 2016;122:3110–3118.

    Article  PubMed  Google Scholar 

  10. Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Human Pathology. 2008;39:1411–1419.

    Article  PubMed  Google Scholar 

  11. Georvasili V, Markopoulos G, Batistatou A et al. Detection of cancer cells and tumor margins during colorectal cancer surgery by intraoperative flow cytometry. International Journal of Surgery (London, England). 2022;104:106717.

    Article  PubMed  Google Scholar 

  12. Casali P, Blay J, Abecassis N et al. Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2022;33:20–33.

    Article  CAS  PubMed  Google Scholar 

  13. Nishida T, Yoshinaga S, Takahashi T, Naito Y. Recent Progress and Challenges in the Diagnosis and Treatment of Gastrointestinal Stromal Tumors. Cancers. 2021; 13.

  14. Oppelt P, Hirbe A, Van Tine B. Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review. Journal of Gastrointestinal Oncology. 2017;8:466–473.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Zhang Jing-wen, Cao Xin-guang, Dai Nan et al. Efficacy analysis of endoscopic treatment of giant gastric gastrointestinal stromal tumors (≥5 cm). [J]. Eur J Surg Oncol, 2023, undefined: undefined.

  16. Koo D, Ryu M, Kim K et al. Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor. Cancer Research and Treatment. 2016;48:1155–1166.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Casali P, Le Cesne A, Velasco A et al. Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS). Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2021;32:533–541.

    Article  CAS  PubMed  Google Scholar 

  18. Shannon A, Song Y, Fraker D et al. Do microscopic surgical margins matter for primary gastric gastrointestinal stromal tumor? Surgery. 2021;169:419–425.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank all patients for their participation in this study. In addition, we want to thank Prof. Bingrong Liu and Prof. Saif Ullah for their help in revising this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

Data collection: JZ, ND, SZ, XW. Data analysis and drafting: JZ, PL, FZ, YF. Critical review and rewriting: GN, XC, CG.

Corresponding author

Correspondence to Xin-gung Cao.

Ethics declarations

Conflict of interest

The scientific guarantors of this publication are Xinguang Cao. The authors of this manuscript (Jing-wen Zhang, Chang-qing Guo, Shan-shan Zhu, Ghulam Nabi, Nan Dai, Xiao-yu Wan, Ping Liu, Fang-bin Zhang, Yang Fu, Xin-gung Cao) declare no relationships with any companies, whose products or services may be related to the subject matter of the article. The authors of this manuscript (Jing-wen Zhang, Chang-qing Guo, Shan-shan Zhu, Ghulam Nabi, Nan Dai, Xiao-yu Wan, Ping Liu, Fang-bin Zhang, Yang Fu, Xin-gung Cao) declare that they have no conflict of interests. The protocol was approved by The First Affiliated Hospital of Zhengzhou University (No.2022-KY-1236-001) and informed consent was waived. All the authors have followed the applicable ethical standards to maintain the research integrity without any duplication, fraud or plagiarism issues.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Jw., Guo, Cq., Zhu, Ss. et al. Comparative Analysis of Enbloc or Piecemeal Removal After Enbloc Resection of Gastrointestinal Stromal Tumors. Dig Dis Sci (2024). https://doi.org/10.1007/s10620-024-08340-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10620-024-08340-w

Keywords

Navigation